Gain Therapeutics, Inc. (GANX) NASDAQ
2.43
-0.32(-11.64%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.43
-0.32(-11.64%)
Currency In USD
| Market Cap | 49.42M |
| Enterprise Value | 39.69M |
| P/E Ratio | -4.39 |
| PEG Ratio | -1.45 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 14.39 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -4.9 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.77 |
| Return On Equity | -3.41 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -20.27M |
| Net Income | -20.41M |
| Diluted EPS | -0.89 |
| Total Cash | 8.81M |
| Total Cash/Share | 0.25 |
| Total Debt | 605,278 |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.52 |
| Book Value Per Share | 0.17 |
| 52-Week Change | 15.17 |
| 52-Week High | 4.34 |
| 52-Week Low | 1.41 |
| Moving Average 50 Days | 2.25 |
| Moving Average 200 Days | 2.15 |
| Average Volume | 1.22M |
| Shares Outstanding | 38.46M |
| % Held by Institutions | 23.03 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |